Point72 Asset Management »

First Tracks Biotherapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.2M 408k 20.12

More positions owned by Point72 Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Amazon (AMZN)
Asml Hldg Nv N Y Registry Shs (ASML)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Procter & Gamble Company (PG)
Arista Networks Com Shs (ANET)
MKS Instruments (MKSI)
Seagate Technology Hldngs Pl Ord Shs (STX)
Snowflake Com Shs (SNOW)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Oracle Corporation (ORCL)
Raytheon Technologies Corp (RTX)
Broadcom (AVGO)

View all positions for Point72 Asset Management

Top funds holding First Tracks Biotherapeutics

FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Sanofi
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Arrowstreet Capital, Limited Partnership
Federated Investors
Ally Bridge Group

View all funds holding First Tracks Biotherapeutics